Summary

Health Sensors Market Growth & Trends

The global health sensors market size is anticipated to reach USD 142.18 billion by 2030, registering a CAGR of 19.07% over the forecast period, according to a new report by Grand View Research, Inc. The market is expected to grow due to the increasing geriatric population, growing inclination towards fitness, and increasing prevalence of chronic diseases. In the current complex healthcare environment, the need for advanced and accurate monitoring systems increases as healthcare organizations progress to provide better services. Health sensors is continuously evolving from ad-hoc to continuous monitoring to provide accurate data to clinicians to make treatment decisions.

The main focus of hospitals and healthcare providers is to get reliable data and lower-cost devices, which is considered the first step toward technological advancement. Moreover, technological advancements in health sensors devices can support clinicians in identifying patients with high risk of disease, which is anticipated to spur industry growth. For instance, in January 2021, Biosticker is a highly on-body advanced sensor that allows effortless monitoring of vital signs and actionable insights provided to clinicians from patients in hospitals or homecare settings, which can create a unique opportunity for the early detection of complications. As a result of this, the industry is expected to grow.

The COVID-19 outbreak is expected to have a positive impact on the overall industry. This is due the factors, such as high product demand to remotely monitor the health status of patients infected with coronavirus or self-quarantined individuals taking treatment in a personal room, to reduce the transmission rate of COVID-19 infectious among the caregivers, surgeons, patients of other diseases, and hospital management personnel as wearable technology enables the caregivers & surgeons to check patients in real-time, and others. The coronavirus outbreak has also compelled a complete reassessment of clinical trial design. The use of wearables in decentralized clinical trials is one area with significant potential (DCTs).

Health Sensors Market Report Highlights

• Based on product, the wearable sensors segment held the market with the largest revenue share of 40.57% in 2023.

• Based on type, the heart rate segment led the market with the largest revenue share in 2023 due to its prominent role in monitoring the health of patients.

• In terms of application, the chronic illness & at-risk-monitoring led the market with largest revenue share of 22.75% in 2023.

• North America dominated the market with a revenue share of 34.6% in 2023. This can be attributed to its well-established healthcare infrastructure, high healthcare expenditure, presence of dominant players, and rapid adoption of advanced technologies.

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Health Sensors Market: Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Type Segment
1.1.1.2. Product Segment
1.1.1.3. Application Segment
1.1.1.4. End use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information Or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Primary Sources
1.11. List of Abbreviations
Chapter 2. Health Sensors Market: Executive Summary
2.1. Market Snapshot
2.2. Type and Product Snapshot
2.3. Application and End Use Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Health Sensors Market: Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.4.1. Increasing Demand for Health Data Tracking
3.4.2. Sensor Innovation & Miniaturization
3.4.3. Rising Demand for Round-the-clock Monitoring
3.4.4. Growing Inclination Towards Fitness
3.4.5. Care Moving from Hospital to Home
3.4.6. Increasing Prevalence of Chronic Conditions
3.5. Market Restraint Analysis
3.5.1. Data security & privacy issues
3.5.2. Non-availability of reimbursement
3.6. Health Sensors Market Analysis Tools
3.6.1. Industry Analysis - Porter’s
3.6.1.1. Supplier Power
3.6.1.2. Buyer Power
3.6.1.3. Substitution Threat
3.6.1.4. Threat of New Entrant
3.6.1.5. Competitive Rivalry
3.6.2. PESTLE Analysis
3.6.2.1. Political Landscape
3.6.2.2. Technological Landscape
3.6.2.3. Economic Landscape
3.6.3. Pricing Analysis
Chapter 4. Health Sensors: Type Estimates & Trend Analysis
4.1. Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Health Sensors Market by Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
4.4.1. Temperature Sensors
4.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.2. Pressure Sensors
4.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.3. Blood Glucose Sensors
4.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.4. Blood Oxygen Sensors
4.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.5. Electrocardiogram (ECG) Sensors
4.4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.6. Motion Sensors
4.4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.7. Image Sensors
4.4.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.8. Flow Sensors
4.4.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.9. Heart Rate Sensors
4.4.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
4.4.10. Others
4.4.10.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 5. Health Sensors: Product Estimates & Trend Analysis
5.1. Product Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Health Sensors Market by Product Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
5.4.1. Handheld Diagnostic Sensors
5.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.1.1.1. Chronic Illness & At Risk-Monitoring
5.4.1.1.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.1.1.2. Patient Admission Triage
5.4.1.1.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.1.1.3. Logistical Tracking
5.4.1.1.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.1.1.4. In Hospital Clinical Monitoring
5.4.1.1.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.1.1.5. Post Acute Care Monitoring
5.4.1.1.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.2. Wearable Sensors
5.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.2.1.1. Disposable Wearable Sensors
5.4.2.1.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.2.1.2. Non-Disposable Wearable Sensors
5.4.2.1.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.2.1.2.1.1. Wellness Monitoring
5.4.2.1.2.1.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.2.1.2.1.2. Chronic Illness & At Risk-Monitoring
5.4.2.1.2.1.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.2.1.2.1.3. Patient Admission Triage
5.4.2.1.2.1.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.2.1.2.1.4. Logistical Tracking
5.4.2.1.2.1.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.2.1.2.1.5. In Hospital Clinical Monitoring
5.4.2.1.2.1.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.2.1.2.1.6. Sensor Therapeutics
5.4.2.1.2.1.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.2.1.2.1.7. Post Acute Care Monitoring
5.4.2.1.2.1.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.3. Implantable/Ingestible Sensors
5.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.3.1.1. Chronic Illness & At Risk-Monitoring
5.4.3.1.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.3.1.2. Patient Admission Triage
5.4.3.1.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.3.1.3. Logistical Tracking
5.4.3.1.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.3.1.4. In Hospital Clinical Monitoring
5.4.3.1.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
5.4.3.1.5. Post Acute Care Monitoring
5.4.3.1.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 6. Health Sensors: Application Estimates & Trend Analysis
6.1. Application Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Health Sensors Market by Application Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
6.4.1. Handheld Diagnostic Sensors
6.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.2. Chronic Illness & At Risk-Monitoring
6.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.3. Wellness Monitoring
6.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.4. Patient Admission Triage
6.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.5. Logistical Tracking
6.4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.6. In Hospital Clinical Monitoring
6.4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.7. Sensor Therapeutics
6.4.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.8. Post-Acute Care Monitoring
6.4.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.8.1.1. Home-Based
6.4.8.1.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.8.1.2. Others
6.4.8.1.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 7. Health Sensors: End Use Estimates & Trend Analysis
7.1. End Use Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. Global Health Sensors Market by End Use Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
7.4.1. Hospitals & Clinics
7.4.1.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.4.2. Long-term care centers & Nursing homes
7.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.4.3. Home Care Settings
7.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.4.4. Others
7.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Regional Market Share Analysis, 2023 & 2030
8.2. Regional Market Dashboard
8.3. Global Regional Market Snapshot
8.4. Marker Size, & Forecasts Trend Analysis, 2018 to 2030:
8.5. North America
8.5.1. U.S.
8.5.1.1. Key Country Dynamics
8.5.1.2. Competitive Scenario
8.5.1.3. Regulatory Framework
8.5.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.5.2. Canada
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.6. Europe
8.6.1. UK
8.6.1.1. Key Country Dynamics
8.6.1.2. Competitive Scenario
8.6.1.3. Regulatory Framework
8.6.1.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.6.2. Germany
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.6.3. Spain
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.6.4. France
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.6.5. Italy
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.6.6. Denmark
8.6.6.1. Key Country Dynamics
8.6.6.2. Competitive Scenario
8.6.6.3. Regulatory Framework
8.6.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.6.7. Sweden
8.6.7.1. Key Country Dynamics
8.6.7.2. Competitive Scenario
8.6.7.3. Regulatory Framework
8.6.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.6.8. Norway
8.6.8.1. Key Country Dynamics
8.6.8.2. Competitive Scenario
8.6.8.3. Regulatory Framework
8.6.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.7. Asia Pacific
8.7.1. JAPAN
8.7.1.1. Key Country Dynamics
8.7.1.2. Competitive Scenario
8.7.1.3. Regulatory Framework
8.7.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.7.2. China
8.7.2.1. Key Country Dynamics
8.7.2.2. Competitive Scenario
8.7.2.3. Regulatory Framework
8.7.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.7.3. India
8.7.3.1. Key Country Dynamics
8.7.3.2. Competitive Scenario
8.7.3.3. Regulatory Framework
8.7.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.7.4. South Korea
8.7.4.1. Key Country Dynamics
8.7.4.2. Competitive Scenario
8.7.4.3. Regulatory Framework
8.7.4.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.7.5. Thailand
8.7.5.1. Key Country Dynamics
8.7.5.2. Competitive Scenario
8.7.5.3. Regulatory Framework
8.7.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.7.6. Australia
8.7.6.1. Key Country Dynamics
8.7.6.2. Competitive Scenario
8.7.6.3. Regulatory Framework
8.7.6.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.8. Latin America
8.8.1. Brazil
8.8.1.1. Key Country Dynamics
8.8.1.2. Competitive Scenario
8.8.1.3. Regulatory Framework
8.8.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.8.2. Mexico
8.8.2.1. Key Country Dynamics
8.8.2.2. Competitive Scenario
8.8.2.3. Regulatory Framework
8.8.2.4. Mexico Health Sensors Market, 2018-2030 (USD Million)
8.8.3. Argentina
8.8.3.1. Key Country Dynamics
8.8.3.2. Competitive Scenario
8.8.3.3. Regulatory Framework
8.8.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.9. MEA
8.9.1. MEA Health Sensors Market, 2018-2030 (USD Million)
8.9.2. South Africa
8.9.2.1. Key Country Dynamics
8.9.2.2. Competitive Scenario
8.9.2.3. Regulatory Framework
8.9.2.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.9.3. Saudi Arabia
8.9.3.1. Key Country Dynamics
8.9.3.2. Competitive Scenario
8.9.3.3. Regulatory Framework
8.9.3.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.9.4. UAE
8.9.4.1. Key Country Dynamics
8.9.4.2. Competitive Scenario
8.9.4.3. Regulatory Framework
8.9.4.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
8.9.5. Kuwait
8.9.5.1. Key Country Dynamics
8.9.5.2. Competitive Scenario
8.9.5.3. Regulatory Framework
8.9.5.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, by Key Market Participants
9.2. Company /Competition Categorization
9.3. Vendor Landscape
9.3.1. List of Key Distributors and Channel Partners
9.3.2. Key Customers
9.3.3. Key Company Market Share Analysis, 2023
9.3.4. Analog Devices Inc
9.3.4.1. Overview
9.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.4.3. Product Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. Avago Technologies Ltd.,
9.3.5.1. Overview
9.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.5.3. Product Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Danaher Corporation
9.3.6.1. Overview
9.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.6.3. Product Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. GE Healthcare
9.3.7.1. Overview
9.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.7.3. Product Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Honeywell International Inc.
9.3.8.1. Overview
9.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.8.3. Product Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Medtronic Plc.,
9.3.9.1. Overview
9.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.9.3. Product Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. Smith’s Medical Inc.
9.3.10.1. Overview
9.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.10.3. Product Benchmarking
9.3.10.4. Strategic Initiatives
9.3.11. Koninklijke Philips
9.3.11.1. Overview
9.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.11.3. Product Benchmarking
9.3.11.4. Strategic Initiatives
9.3.12. Sensirion AG
9.3.12.1. Overview
9.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.12.3. Product Benchmarking
9.3.12.4. Strategic Initiatives
9.3.13. Abbott Laboratories
9.3.13.1. Overview
9.3.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.13.3. Product Benchmarking
9.3.13.4. Strategic Initiatives
9.3.14. F. Hoffmann-La Roche AG
9.3.14.1. Overview
9.3.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.14.3. Product Benchmarking
9.3.14.4. Strategic Initiatives
9.3.15. Hologic, Inc.
9.3.15.1. Overview
9.3.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.15.3. Product Benchmarking
9.3.15.4. Strategic Initiatives
9.3.16. Varian Medical System
9.3.16.1. Overview
9.3.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.16.3. Product Benchmarking
9.3.16.4. Strategic Initiatives